Free Webinars
Transitioning to FDA’s New Premarket Submission Guidance
November 15, 2023
•
30
minutes
CEO Erez Kaminski and former FDA expert Paul Jones review the 2023 Premarket Submission Guidance and how teams can better understand—and implement—new expectations for product development and submission.